(1)
Radiographic Progression of Structural Joint Damage in Patients With Active Psoriatic Arthritis Treated With Ixekizumab over 52 Weeks. J of Skin 2018, 2 (S1), S14. https://doi.org/10.25251/skin.2.supp.14.